[ASC-media] Media Release: Richest prize for innovation
jca-media at starclass.com.au
Tue Mar 25 21:56:05 EST 2003
CFFI MEDIA RELEASE
AUSTRALIA HAILS ITS INNOVATORS
The nation's most valuable prize for innovation, the $100,000 Peter Doherty Prize will be awarded for the first time at the Commercialisation Forum & Fair of Ideas in Sydney on Thursday (March 27).
Named after Australia's 1996 Nobel Laureate in Medicine, Professor Peter Doherty, the prize will go to the most outstanding commercialisation and investment opportunity among the many technologies featured at CFFI.
Entrants are from among 200 cutting edge, market-ready technologies submitted by Australia's leading universities and science agencies.
The winner of the inaugural peter Doherty Prize will be chose from a short list of outstanding Australian technologies. These are:
" New way to measure high voltage power. Australian Photonics PL, 02 9209 4868
" Inhalix: Hayfever Prevention. University of Sydney Business Liaison Office, 02 9351 2219
" Liver iron measurement using MRI. University of WA Office of Industry. 08 9380 7048
" Magic Wand Laser. Macquarie Research Ltd. 02 9850 9296
" Medsaic: personalised medicine using a protein nano-array platform. University of Sydney, Business Liaison Office. 02 9351 8778.
" "Mind Switch" - hands-free control of electrical devices. University of Technology Sydney. 02 9514 1358.
" "Objectivision" - a revolutionary glaucoma test. University of Sydney, Business Liaison Office. 02 9351 2219.
" Transient blocking unit - a device to protect electrical telecommunication interfaces. Uniquest PL, University of Queensland. 07 3365 4037.
" Intratumor administration of CV A21 for control of malignant melanoma. Viro Targ PL, University of Newcastle. 02 49236158.
" WTI - innovation in welding with Weldprint. University of Sydney, Business Liaison Office. 02 9351 6745.
The winner will be chosen based on the potential of the technology, the realism of the business opportunity, understanding of the market, commercial expertise in the team and investment plans.
The Peter Doherty Prize is worth $100,000, consisting of $40,000 in cash and $60,000 in kind. Sponsors of the prize are PricewaterhouseCoopers, the Australian Institute for Commercialisation Ltd., the ResMed Foundation and Knowledge Commercialisation Australasia.
The winner will be announced and presentation of the Peter Doherty Prize will take place at the CFFI Forum at 10AM on Thursday, March 27, at the Sydney Convention and Exhibition Centre, Darling Harbour, Sydney, March 26-28.
There will be free admittance to visitors to the CFFI Fair on Wednesday March 26 (only). Please download a free pass from: www.kca.asn.au
The Commercialisation Forum & Fair is one of the initial events in the Australian Innovation festival in May 2003.
More information on CFFI:
Mr Bob Taylor, CFFI coordinator 0409 855 993
Bob.taylor at flinders.edu.au
Mr Paul Field, Aust. Technology Park 0417 299 837
p.field at atp-innovations.com.au
Julian Cribb, media contact 0418 639 245
Julian.cribb at csiro.au
Peter Doherty - bio details
Peter Doherty works in the general area of immunity to viruses and shared the 1996 Nobel Prize for Physiology or Medicine with his Swiss Colleague, Rolf Zinkernagel, for discovering "the nature of the cellular immune defence". He was Australian of the Year in 1997, and has (since 1998) been commuting between St Jude Children's Research Hospital (SJCRH) in Memphis, Tennessee, and the Department of Microbiology and Immunology at the University of Melbourne. He recently returned to Australia, holding appointments as Laureate Professor at Melbourne and Burnet Fellow of the National Health and Medical Research Council.
Doherty's trained in veterinary science at the University of Queensland, and is the first veterinary scientist to win a Nobel Prize. He worked as a vet in the Queensland Department of Primary Industries, then completed a Ph.D. in pathology at the University of Edinburgh Medical School. The discovery that won the Nobel Award was made during his tenure as a Research Fellow at the John Curtin School of Medical Research (JCSMR), Canberra.
More information about the ASC-media